Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA187905
Max Phase: Preclinical
Molecular Formula: C23H20O3
Molecular Weight: 344.41
Molecule Type: Small molecule
Associated Items:
ID: ALA187905
Max Phase: Preclinical
Molecular Formula: C23H20O3
Molecular Weight: 344.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)Oc2ccc(C)cc2C(=O)c2ccc(C)cc2)cc1
Standard InChI: InChI=1S/C23H20O3/c1-15-4-9-18(10-5-15)22(24)20-14-17(3)8-13-21(20)26-23(25)19-11-6-16(2)7-12-19/h4-14H,1-3H3
Standard InChI Key: QVZAYUPDQCYYHT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 344.41 | Molecular Weight (Monoisotopic): 344.1412 | AlogP: 5.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.37 | Molecular Species: | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.63 | CX LogD: 6.63 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.38 | Np Likeness Score: -0.51 |
1. Khanum SA, Murari SK, Vishwanth BS, Shashikanth S.. (2005) Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes., 15 (18): [PMID:15993585] [10.1016/j.bmcl.2005.06.012] |
2. Venu TD, Shashikanth S, Khanum SA, Naveen S, Firdouse A, Sridhar MA, Shashidhara Prasad J.. (2007) Synthesis and crystallographic analysis of benzophenone derivatives--the potential anti-inflammatory agents., 15 (10): [PMID:17376692] [10.1016/j.bmc.2007.02.051] |
Source(1):